SCHEMBL6812665

SCHEMBL6812665

CC(C(O)c1cc(F)c(O)c(F)c1)N1CCC(O)(c2ccccc2)CC1.CS(=O)(=O)O

nearest known ligand 0.65

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
GRIN2D known ✓ O15399 1/20 0.63
GRIN3B known ✓ O60391 1/20 0.63
GRIN1 known ✓ Q05586 1/20 0.63
GRIN2A known ✓ Q12879 1/20 0.63
GRIN2B known ✓ Q13224 1/20 0.63
GRIN2C known ✓ Q14957 1/20 0.63
GRIN3A known ✓ Q8TCU5 1/20 0.63
KCNH2 Q12809 6/20 0.63
CYP2D6 P10635 5/20 0.63
OPRM1 P35372 4/20 0.49
OPRD1 P41143 4/20 0.49
OPRK1 P41145 4/20 0.49
OPRL1 P41146 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8059205 1.00 KCNH2 (0.63) KCNH2CYP2D6GRIN2DGRIN3BGRIN1
SCHEMBL7946764 0.93 CYP2D6 (0.61) KCNH2CYP2D6GRIN2DGRIN3BGRIN1
SCHEMBL7946766 0.93 CYP2D6 (0.61) KCNH2CYP2D6GRIN2DGRIN3BGRIN1
SCHEMBL8062623 0.91 CYP2D6 (0.57) KCNH2CYP2D6GRIN2DGRIN3BGRIN1
SCHEMBL8062625 0.91 CYP2D6 (0.57) KCNH2CYP2D6GRIN2DGRIN3BGRIN1
SCHEMBL7952039 0.91 CYP2D6 (0.63) KCNH2CYP2D6GRIN2DGRIN3BGRIN1
SCHEMBL6816939 0.91 CYP2D6 (0.63) KCNH2CYP2D6GRIN2DGRIN3BGRIN1
SCHEMBL7947828 0.89 CYP2D6 (0.50) KCNH2CYP2D6GRIN2DGRIN3BGRIN1
SCHEMBL7947830 0.89 CYP2D6 (0.50) KCNH2CYP2D6GRIN2DGRIN3BGRIN1
SCHEMBL7952208 0.88 CYP2D6 (0.64) KCNH2CYP2D6GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0828513-B1 COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS PFIZER (US) 2004-01-21 EP disclosed
EP-0777652-B1 NEUROPROTECTIVE 3-(PIPERIDINYL-1)-CHROMAN-4,7-DIOL AND 1-(4-HYDROPHENYL)-2-(PIPERIDINYL-1)-ALKANOL DERIVATIVES PFIZER (US) 2003-06-25 EP disclosed
US-6258827-B1 HYDROXYAROMATIC HETEROCYCLIC ALKANOLS AND LEVODOPA PFIZER INC. 2001-07-10 US disclosed
US-6046213-A Neuroprotective 3-(piperidinyl-1)-chroman-4,7-diol and 1-(4-hydroxyphenyl)-2-(piperidinyl-1)-alkanol derivatives PFIZER INC. (US) 2000-04-04 US disclosed
EP-0828513-A2 COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS PFIZER INC. (US) 1998-03-18 EP disclosed
EP-0777652-A1 NEUROPROTECTIVE 3-(PIPERIDINYL-1)-CHROMAN-4,7-DIOL AND 1-(4-HYDROPHENYL)-2-(PIPERIDINYL-1)-ALKANOL DERIVATIVES PFIZER INC. (US) 1997-06-11 EP disclosed
WO-1996037226-A2 COMBINATIONS FOR THE TREATMENT OF PARKINSONISM CONTAINING SELECTIVE NMDA ANTAGONISTS PFIZER INC. (US) 1996-11-28 WO disclosed
WO-1996006081-A1 NEUROPROTECTIVE 3-(PIPERIDINYL-1)-CHROMAN-4,7-DIOL AND 1-(4-HYDROPHENYL)-2-(PIPERIDINYL-1)-ALKANOL DERIVATIVES PFIZER INC. (US) 1996-02-29 WO disclosed